Targeting mechanisms associated with CIN-driven cancer necessitates strategies to counteract the altered immune landscape, exploit metabolic vulnerabilities, manipulate CIN effects, target the extracellular matrix, and address metastasis and STING signaling pathways. Here, STING1 is linked to cervical squamous intraepithelial neoplasia.